Suruchi Mohan1,2, Shuja Reagu2,3, Stephen Lindow4, Majid Alabdulla3,5. 1. Department of Obstetrics and Gynaecology, Sidra Medicine, Doha, Qatar. 2. Weill Cornell Medicine, Doha, Qatar. 3. Department of Psychiatry, Mental Health Services, Hamad Medical Corporation, Doha, Qatar. 4. Department of Obstetrics and Gynaecology, Coombe Women and Infants University Hospital, Dublin, Ireland. 5. College of Medicine, Qatar University, Doha, Qatar.
Abstract
OBJECTIVES: To explore attitudes to COVID-19 vaccination among perinatal women. METHODS: A nationwide online, cross-sectional survey was conducted in Qatar from 15th October 2020 to 15th November 2020 with voluntary participation open to all adult residents. Of the respondents, the population group for this study comprised the 341 pregnant and breastfeeding participants. The survey utilized a composite questionnaire incorporating a validated instrument to measure vaccine attitudes. The responses were recorded and analysed with statistical analysis being performed with SPSS software. Outcome measures included intentions towards vaccination and potential factors influencing vaccine hesitancy (contextual factors, vaccine specific concerns and group/individual influences). RESULTS: Perinatal women exhibited a vaccine hesitancy rate of 25% towards COVID-19 immunisation. The main concerns of the group were of infection risks and main factor determining vaccine hesitancy was of vaccine specific safety concerns. Previous vaccine "acceptors" showed vaccine hesitancy to COVID-19 immunisation. A third of the group cited non availability of the vaccine as a concern. CONCLUSIONS: COVID-19 vaccine trials amongst pregnant and lactating women have lagged behind those for general populations and this has compounded concerns around safety in this special group. Perinatal women constitute a vulnerable group and play an important role in vaccination of wider family members. This study highlights the need for trials and data for COVID-19 vaccine in this group to be able to achieve appreciable numbers needed for herd immunity and ultimately control of the pandemic.
OBJECTIVES: To explore attitudes to COVID-19 vaccination among perinatal women. METHODS: A nationwide online, cross-sectional survey was conducted in Qatar from 15th October 2020 to 15th November 2020 with voluntary participation open to all adult residents. Of the respondents, the population group for this study comprised the 341 pregnant and breastfeeding participants. The survey utilized a composite questionnaire incorporating a validated instrument to measure vaccine attitudes. The responses were recorded and analysed with statistical analysis being performed with SPSS software. Outcome measures included intentions towards vaccination and potential factors influencing vaccine hesitancy (contextual factors, vaccine specific concerns and group/individual influences). RESULTS: Perinatal women exhibited a vaccine hesitancy rate of 25% towards COVID-19 immunisation. The main concerns of the group were of infection risks and main factor determining vaccine hesitancy was of vaccine specific safety concerns. Previous vaccine "acceptors" showed vaccine hesitancy to COVID-19 immunisation. A third of the group cited non availability of the vaccine as a concern. CONCLUSIONS:COVID-19 vaccine trials amongst pregnant and lactating women have lagged behind those for general populations and this has compounded concerns around safety in this special group. Perinatal women constitute a vulnerable group and play an important role in vaccination of wider family members. This study highlights the need for trials and data for COVID-19 vaccine in this group to be able to achieve appreciable numbers needed for herd immunity and ultimately control of the pandemic.
Authors: Mustafa Abdul Karim; Shuja M Reagu; Sami Ouanes; Abdul Waheed Khan; Wesam S Smidi; Nadeen Al-Baz; Majid Alabdulla Journal: Medicine (Baltimore) Date: 2022-07-01 Impact factor: 1.817
Authors: Luigi Carbone; Raffaella Di Girolamo; Ilenia Mappa; Gabriele Saccone; Antonio Raffone; Daniele Di Mascio; Valentino De Vivo; Francesco D'Antonio; Maurizio Guida; Giuseppe Rizzo; Giuseppe Maria Maruotti Journal: Eur J Obstet Gynecol Reprod Biol Date: 2021-12-07 Impact factor: 2.435
Authors: Sławomir Januszek; Natalia Siwiec; Rafał Januszek; Marta Kluz; Roman Lebed; Paweł Toś; Tomasz Góra; Krzysztof Plens; Krzysztof Dąbrowski; Marcin Sidorowicz; Aleksandra Szcześniewska; Edyta Barnaś; Katarzyna Kalandyk-Osinko; Dorota Darmochwal-Kolarz; Tomasz Kluz Journal: Vaccines (Basel) Date: 2022-02-08
Authors: Abanoub Riad; Anna Jouzová; Batuhan Üstün; Eliška Lagová; Lukáš Hruban; Petr Janků; Andrea Pokorná; Jitka Klugarová; Michal Koščík; Miloslav Klugar Journal: Int J Environ Res Public Health Date: 2021-12-19 Impact factor: 3.390